ExLibris header image
SFX Logo
Title: Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Source:

Nature Neuroscience [1097-6256] Shahmoradian, Sarah yr:2019


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Emre, M. "Rivastigmine for Dementia Associated with Parkinson's Disease." The New England journal of medicine 352.13 (2004): 2509-18. Link to SFX for this item
2. Stefani, A. "Sleep in Parkinson’s disease." Neuropsychopharmacology (New York, N.Y.) 45.1: 121-128. Link to SFX for this item
3. Barichella, M. "Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism." Movement disorders 33.s2: 396-405. Link to SFX for this item
4. Sulzer, D. "The Physiological Role of α-Synuclein and Its Relationship to Parkinson's Disease." Journal of neurochemistry. 150.5: 475-486. Link to SFX for this item
5. Power, John H. "Lewy bodies and the mechanisms of neuronal cell death in parkinson's disease and dementia with lewy bodies." Brain pathology 27.1 (2015): 3-12. Link to Full Text for this item Link to SFX for this item
6. Spiegel, M. "Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study." The lancet 356.9247: 2031-2036. Link to SFX for this item
7. Burn, D. "Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease." Movement disorders 21.11 (2006): 1899-907. Link to Full Text for this item Link to SFX for this item
8. Poewe, W. "Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study." Movement disorders 21.4 (2006): 456-61. Link to Full Text for this item Link to SFX for this item
9. Emre, M. "Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: Similarities and differences." Journal of Alzheimer's disease 11.4 (2007): 509-519. Link to SFX for this item
10. Schneider, Lon S S. "Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease." New England Journal of Medicine, The 355.15 (2006): 1525-38. Link to SFX for this item
11. Brockmann, K. "[Personalized treatment of Parkinson's disease]." Der Nervenarzt. 90.8: 767-772. Link to SFX for this item
12. Nicoletti, A. "Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study." Frontiers in aging neuroscience 11 (2019): 21-21. Link to Full Text for this item Link to SFX for this item
13. Surmeier, Dalton J. "Determinants of dopaminergic neuron loss in Parkinson's disease." FEBS Journal 285.19 (2018): 3657-3668. Link to Full Text for this item Link to SFX for this item
14. Schormair, B. "Diagnostic exome sequencing in early-onset Parkinson's disease confirmsVPS13Cas a rare cause of autosomal-recessive Parkinson's disease." Clinical Genetics 93.3 (2018): 603-612. Link to Full Text for this item Link to SFX for this item
15. Stojkovska, I. "Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease." Cell and tissue research. 373.1: 51-60. Link to SFX for this item
16. "Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review." Evidence-based mental health. 20.1: 15-20. Link to SFX for this item
17. Fung, Thomas C. "Interactions between the microbiota, immune and nervous systems in health and disease." Nature Neuroscience 20.2 (2017): 145-155. Link to SFX for this item
18. Barichella, M. "Probiotics and prebiotic fiber for constipation associated with Parkinson disease." Neurology 87.12 (2016): 1274-1280. Link to SFX for this item
19. Planetta, Peggy J. "Free-water imaging in Parkinson's disease and atypical parkinsonism." Brain 139.2 (2015): 495-508. Link to SFX for this item
20. Scheperjans, F. "Gut microbiota are related to Parkinson's disease and clinical phenotype." Movement disorders 30.3 (2014): 350-8. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.